HIGHLIGHTS
- who: Matthias Reinscheid from the Study cohort In total, individuals receiving SARS-Co, vaccinations were recruited at the Freiburg University Medical Center, GermanyOf those, blood was collected from , individuals vaccinated three times with the mRNA vaccines bnt162b/Comirnaty or mRNA-1273/Spikevax and , individuals receiving a, th vaccination. All vaccinees did not have a history of SARS-Co, infection prior to inclusion confirmed by seronegativity for anti-SARS-Co, nucleocapside IgG (anti-SARS-Co, N IgG). Moreover, blood was collected from , individuals with SARSCo, breakthrough infections after a, rd mRNA vaccination. Breakthrough infections were confirmed by positive . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.